These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 2950167)

  • 1. Interaction in vivo between hapten-specific suppressor T cells and an in vitro cultured helper T cell line.
    Owens T; Miller JF
    J Immunol; 1987 Mar; 138(6):1687-92. PubMed ID: 2950167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
    Miller SD; Butler LD
    J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoregulatory pathways in adult responder mice. III. Establishment of a GAT-specific suppressor T cell clone from GAT-tolerant responders which afferently regulates DTH responses.
    Jenkins MK; Miller SD
    J Mol Cell Immunol; 1985; 2(1):1-13. PubMed ID: 2978221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T helper target cell DNA fragmentation through a CD4-positive T suppressor cell clone inducing specific unresponsiveness.
    Becker C; Konur A; Rademaekers A; Kodelja V; Partenheimer A; Pauels HG; Kölsch E
    Cell Immunol; 1994 Feb; 153(2):505-15. PubMed ID: 7907005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance to Mls-disparate cells induces suppressor T cells that act at the helper level to prevent in vivo generation of cytolytic lymphocytes to hapten-altered self.
    Vargo PM; Battisto JR
    J Immunol; 1984 Jun; 132(6):2796-801. PubMed ID: 6233362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo priming of helper and suppressor T cells by alloantigens. Frequency analysis with the use of an in vitro limiting dilution assay.
    Bianchi AT; Schilham MW; Benner R; Young P; Lefkovits I
    J Immunol; 1987 Oct; 139(8):2524-9. PubMed ID: 2958552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell tolerance.
    Good MF; Nossal GJ
    J Immunol; 1983 Dec; 131(6):2662-9. PubMed ID: 6227660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor T cells, distinct from "veto cells," are induced by alloantigen priming and mediate transferable suppression of cytotoxic T lymphocyte responses in vivo.
    Owens T; Crispe IN
    J Immunol; 1985 Nov; 135(5):2984-9. PubMed ID: 2413108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cyclophosphamide on cytotoxic T-lymphocyte responses: inhibition of helper T-cell induction in vitro.
    Varkila K; Hurme M
    Immunology; 1983 Mar; 48(3):433-8. PubMed ID: 6219062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of tolerance towards TNP entails down-regulation of an autoimmune attack.
    Zöller M; Andrighetto G
    Immunology; 1988 Feb; 63(2):205-12. PubMed ID: 2965095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of cytotoxic T lymphocyte development by a minor stimulating locus-induced suppressor cascade that involves Lyt-1+ suppressor T cells, IA- macrophages, and their factors.
    Chow KP; Battisto JR
    J Immunol; 1988 Feb; 140(4):1005-13. PubMed ID: 2963857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two distinct suppressor T cells acting in concert cause suppression of cytolytic T lymphocyte (CTL) response to hapten-altered self in vivo.
    Gautam SC; Beckman KD; Wong HL; Battisto JR
    J Immunol; 1983 Jun; 130(6):2557-60. PubMed ID: 6222107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of cloned macrophage hybridomas. VI. Differential ability to induce immunity or suppression.
    Kuchroo VK; Minami M; Diamond B; Dorf ME
    J Immunol; 1988 Jul; 141(1):10-6. PubMed ID: 2454255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activation of specific helper and suppressor T cells by the type 2 antigen polyvinylpyrrolidone (PVP).
    Van Buskirk AM; Braley-Mullen H
    J Immunol; 1987 Sep; 139(5):1400-5. PubMed ID: 2957424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic control of hapten-reactive helper T-cell responses and its implications for the generation of augmented antitumor cytotoxic responses.
    Mizushima Y; Fujiwara H; Takai Y; Shearer GM; Hamaoka T
    J Natl Cancer Inst; 1985 Jun; 74(6):1269-73. PubMed ID: 3158772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses.
    Takai Y; Kosugi A; Yoshioka T; Tomita S; Fujiwara H; Hamaoka T
    J Immunol; 1985 Jan; 134(1):108-13. PubMed ID: 3155458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognate interactions between helper T cells and B cells. I. Cloning and helper activity of a lymphokine-dependent helper T cell clone (Th-3).
    Noelle RJ; McCann J
    J Mol Cell Immunol; 1989; 4(3):161-73; discussion 173-5. PubMed ID: 2527511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective reversal of H-2-linked genetic unresponsiveness to lysozymes. II. Alteration in the T helper/T suppressor balance, owing to gene(s) linked to Ir-2, leads to responsiveness in BALB.B.
    Sadegh-Nasseri S; Dessi V; Sercarz EE
    Eur J Immunol; 1986 May; 16(5):486-92. PubMed ID: 2938974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokine profile and activation pattern of two unrelated antigen- or idiotype-specific T suppressor cell clones.
    Pauels HG; Austrup F; Becker C; Schmitt E; Rüde E; Kölsch E
    Eur J Immunol; 1992 Aug; 22(8):1961-6. PubMed ID: 1386311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression.
    Fujiwara H; Moriyama Y; Suda T; Tsuchida T; Shearer GM; Hamaoka T
    J Immunol; 1984 Mar; 132(3):1571-7. PubMed ID: 6198397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.